pMJA219= pcDNA3.1V5-completeTRABV-CMVp
(Plasmid
#116878)
-
Purposemammalian expression vector containing TCR sequences
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 116878 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1V5
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5203
- Total vector size (bp) 8506
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namecomplete TRAV10-TRBV25-CMVp rabbitpolyA
-
Alt nameTCR alpha beta
-
Alt namebidirectional CMV Promoter
-
SpeciesH. sapiens (human)
-
Insert Size (bp)3303
-
GenBank IDMH782476
-
Entrez GeneTRAV10 (a.k.a. TCRAV10S1, TCRAV24S1)
-
Entrez GeneTRBV25-1 (a.k.a. TCRBV11S1A1T, TCRBV25S1, TRBV251)
- Promoter CMV Promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SpeI (not destroyed)
- 3′ cloning site Xbal (not destroyed)
- 5′ sequencing primer not available
- 3′ sequencing primer not available (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byRui Wang, Ronja Pscheid, Ashfaq Ghumra, Marcos Alcocer
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMJA219= pcDNA3.1V5-completeTRABV-CMVp was a gift from Marcos Alcocer (Addgene plasmid # 116878 ; http://n2t.net/addgene:116878 ; RRID:Addgene_116878) -
For your References section:
Towards a surrogate system to express human lipid binding TCRs. Wang R, Pscheid R, Ghumra A, Kan LYL, Cochrane S, Fairclough L, Alcocer MJC. Biotechnol Lett. 2019 Oct;41(10):1095-1104. doi: 10.1007/s10529-019-02713-2. Epub 2019 Jul 26. 10.1007/s10529-019-02713-2 PubMed 31346817